Open Offer Update for Novartis India Ltd Shows Minimal Tenders as of June 24, 2026
The status of the open offer initiated for Novartis India Limited has been disclosed, indicating very low participation from public shareholders regarding the acquisition of a portion of the company's equity.The open offer involves the acquisition of up to 64,19,608 fully paidup equity shares, representing 26% of the Voting Share Capital of Novartis India Ltd. The acquirers in this transaction include WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners, along with designated Persons Acting in Concert (PACs).
As of June 24, 2026, details regarding the number of equity shares tendered by public shareholders were reported across both dematerialized and physical formats. The data highlights the minimal response rate against the offer size.
The breakdown of the open offer tendering is provided below:
| Tender Method | Shares Tendered | Percentage of Offer Size |
|---|---|---|
| Demat Form (Escrow Account) | NIL | NIL% |
| Physical Form (Registrar) | 182 | 0.00% |
The above disclosure pertains to the Equity Shares tendered through the dedicated Open Offer Escrow Demat Account and those received in physical form by the Registrar to the Open Offer, as communicated to the Manager of the Open Offer.
It is clarified that while the tendering figures have been recorded, the shares offered by public shareholders are subject to validation and verification before being accepted by the Acquirers in the open offer. The final number of Equity Shares accepted may differ from the currently reported tendered amount.
NOVARTIND Stock Price Movement
Novartis India Limited saw its stock edge higher on Wednesday, settling at ₹1475 after achieving a marginal gain of 0.20%. The equity found support during trading, which registered 74,128 shares for the pharmaceutical company.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.